alexa Selective Inhibition Of HDAC6 Affects Ciliogenesis And Prevents Glioblastoma Growth
ISSN: 2155-9562

Journal of Neurology & Neurophysiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

13th International Conference on Neurology and Neurosurgery
June 19-21, 2017 Paris, France

Lan B. Hoang-Minh, Loic P. Deleyrolle, Nari Nakamura, Brent A. Reynolds, Matthew R. Sarkisian
University of Florida, USA
Preston A. Wells Jr. Center for Brain Tumor Therapy, USA
Posters & Accepted Abstracts: J Neurol Neurophysiol
DOI: 10.4172/2155-9562-C1-053
Abstract
Introduction: Histone deacetylases (HDACs) are critical regulators of gene expression and have been exploited in the treatment of cancers; however, pan-HDAC inhibitors can lead to off-target effects and toxicity. HDAC6-selective inhibitors have recently garnered interest as they alter the acetylation of non-histone regulatory proteins implicated in tumor-related processes. One critical function of HDAC6 is to regulate cell cycle progression by triggering the retraction of cells’ primary cilium before entering mitosis. We previously reported that cilia are routinely detected in GBM biopsies and that the majority of GBM patient-derived cells can give rise to ciliated progeny. Our preliminary data suggest that cilia persist in all phases of the cell cycle except mitosis. Since recent reports suggest HDAC6 is often overexpressed in GBM biopsies, we hypothesized that inhibiting HDAC6 will slow GBM growth by disrupting ciliogenesis. Objective: To determine the relationship between HDAC6, primary cilia, and GBM cell proliferation. Methods: We treated patient GBM-derived cells with vehicle or ACY-1215, a selective HDAC6 inhibitor, and measured cell viability, cell cycle phase distribution, ciliogenesis, and proliferative abilities of GBM cell lines with or without KIF3A (an essential regulator of ciliogenesis). Results: HDAC6 was expressed in both patient cell lines that we examined. ACY-1215 treatment significantly reduced GBM cell proliferation, increased the number of cells in the G2/M phases, decreased cell viability in a dose-dependent manner (IC50 ~500nM), and increased apoptotic cell death. Surprisingly, ACY-1215 exposure significantly decreased or increased the percentage of ciliated GBM cells, depending on the cell line and time point analyzed post treatment. Notably, ACY-1215 did not affect the viability of GBM cells that lack cilia following the knockout of KIF3A. CONCLUSION: Selective HDAC6 inhibition slows GBM growth by affecting cell cycle progression and cell survival in a KIF3A/cilia-dependent manner. Future studies will focus on elucidating the molecular mechanisms underlying these effects.
Biography

Lan Hoang-Minh completed her doctoral studies in the Department of Biomedical Engineering at the University of Florida in Gainesville, Florida, USA. She is now a postdoctoral fellow in the laboratory of Dr. Matthew Sarkisian, studying the molecular and cellular mechanisms governing the proliferation of glioblastoma cells. Particularly, her postdoctoral work has focused on examining the role and characteristics of primary cilia, small cellular organelles recently frequently observed in human patients’ glioblastoma biopsies and derived cell lines. In collaboration with a strong team of brain tumor investigators at the University of Florida, she has been investigating how these organelles and associated proteins may be involved in tumor pathogenesis and possibly resistance to standard-of-care therapy. She has also been collaborating with Dr. Loic Deleyrolle in examining the metabolic characteristics of fast and slow-cycling glioblastoma cells and various metabolic strategies to target those cell populations. She recently received a two-year American Brain Tumor Association Basic Research Fellowship Grant.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]e.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version